Henry Schein announced it has completed the acquisition of TriMed, developer of solutions for the orthopedic treatment of lower extremities and upper extremities. Headquartered in Santa Clarita, CA, TriMed had 2023 net sales of approximately $52M. Henry Schein expects the transaction to be neutral to 2024 non-GAAP earnings per share and accretive thereafter. Financial terms were not disclosed.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HSIC: